Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
27.08
+1.36 (5.29%)
At close: Sep 16, 2025, 4:00 PM EDT
27.22
+0.14 (0.52%)
Pre-market: Sep 17, 2025, 8:14 AM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $1.63 billion as of September 17, 2025. Its market cap has decreased by -36.83% in one year.
Market Cap
1.63B
Enterprise Value
1.48B
1-Year Change
-36.83%
Ranking
Category
Stock Price
$27.08
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $1.63B, an increase of 338.76%. That is a compound annual growth rate of 23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.55B | -43.72% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | 6.82B | 881.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |